TCT-62 A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial.
Saved in:
| Title: | TCT-62 A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial. |
|---|---|
| Authors: | Goueffic, Yann1 (AUTHOR), Sauguet, Antoine2 (AUTHOR), Desgranges, Pascal3 (AUTHOR), Feugier, Patrick4 (AUTHOR), Rosset, Eugenio5 (AUTHOR), Ducasse, Eric6 (AUTHOR), Cardon, Alain7 (AUTHOR), Salomon du Mont, Lucie8 (AUTHOR), Pernes, Jean Marc9 (AUTHOR), Commeau, Philippe10 (AUTHOR), Lermusiaux, Patrick11 (AUTHOR), Leclere, Brice12 (AUTHOR), Guyomarch, Beatrice12 (AUTHOR), Hoffmann, Clement13 (AUTHOR), Maurel, Blandine12 (AUTHOR) |
| Source: | Journal of the American College of Cardiology (JACC). 2019Supplement, Vol. 74 Issue 13, pB62-B62. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
